PR98036

BOLOGNA, Italy, Sept. 26, 2022 /PRNewswire=KYODO JBN/ --

The International Symposium on Technological Innovations in Laboratory

Hematology, (ISLH 2022), was held between September 8-10 in Bologna, Italy.

This event saw Mindray ( https://www.mindray.com/en/) (SZSE: 300760), a global

leading developer and provider of medical devices and solutions, showcase their

hematology innovations and academic achievements to medical experts from Europe

and around the world.

Held annually, the symposium serves as an international platform where the

latest technology, new ideas and research findings in laboratory hematology are

showcased and shared.  

During ISLH 2022, Mindray held a seminar themed "The New Era of Digital

Morphology", where Prof. Gina Zini and Prof. Anna Merino, two renowned experts

in morphology, presented an evaluation of the outstanding performance of

Mindray MC-80 Digital Cell Morphology Analyzer (

https://www.mindray.com/en/products/laboratory-diagnostics/hematology/cellular-analysis-line/mc-80?utm_medium=referral&utm_source=pr-newswire&utm_campaign=ISLH22

) in detecting onco-hematological diseases by referring to special clinical

cases, and introduced how MC-80, through high-resolution blood cell images, can

help doctors screen and diagnose malignant and non-malignant blood diseases,

respectively.

During the ISLH poster session, 32 posters from Mindray's hematology end users

are presented after stringent evaluation based on unique insights and

exceptional academic values, outnumbering all other exhibitors.

https://mma.prnewswire.com/media/1907397/Mindray_ISLH_Video.mp4

Before ISLH, Mindray attracted over 700 participants to the HemaTalk Italy 2022

Global Live Event (

https://www.mindray.com/en/events/hematalk?utm_medium=referral&utm_source=pr-newswire&utm_campaign=hematalkitaly22

). Dr. Ramon Simon-Lopez from Mindray IVD Scientific Research and Medical

Affairs, noted that the company has been utilizing its global resources to

build a learning and exchange platform for global medical experts and empower

the future of laboratory medicine.

The attendees had an online conversation with Mindray R&D team to discuss the

future of laboratory hematology and the latest trends in translating clinical

research results into practice. A Q&A session followed where the attendees had

their most-concerned questions answered by Mindray experts.

At its booth at ISLH 2022, Mindray showcased its new MC-80 Digital Cell

Morphology Analyzer (

https://www.mindray.com/en/products/laboratory-diagnostics/hematology/cellular-analysis-line/mc-80?utm_medium=referral&utm_source=pr-newswire&utm_campaign=ISLH22

) and the BC-700 Series Hematology Analyzer (

https://www.mindray.com/en/products/laboratory-diagnostics/hematology/5-part-differential-analyzers/bc-700-series?utm_medium=referral&utm_source=pr-newswire&utm_campaign=ISLH22

), attracting much interest from visitors.

Mindray's academic strength was also recognized by the ISLH committee, who

granted Mindray the "Berend Houwen Travel Award" for outstanding contributions

to the industry and excellence in academics.

About Mindray

Founded in 1991, Mindray is one of the leading global providers of medical

devices and solutions. We are dedicated to innovation in the fields of Patient

Monitoring & Life Support, In-Vitro Diagnostics, Medical Imaging System and

Orthopaedics. Today, Mindray's products and services are available in over 190

countries and regions.

www.mindray.com .

Rita Wang

rita.wang@mindray.com

SOURCE  Mindray

Image Attachments Links:

   Link: http://asianetnews.net/view-attachment?attach-id=430386

   Caption: Mindray

   Link: http://asianetnews.net/view-attachment?attach-id=430389

   Caption: Mindray